Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT01536002
Eligibility Criteria:
Inclusion Criteria:
* Consecutive patients admitted to the Aker University Hospital, scheduled for general or bariatric surgery,
* Both genders. Female subjects of childbearing potential must be using adequate contraception (i.e. using oral or IM contraception or an IUCD) and must have a negative pregnancy test (urine beta-HCG).
* Aged 18 - 60 years, both inclusive
* Body mass index (BMI) ≥ 20 kg/m2
* Written informed consent
Exclusion Criteria:
* Patients that are considered not to tolerate a standard dose of propofol administered as a bolus.
* Known hypersensitivity to propofol or its ingredients (soy, lecithin, glycerol, oil acid)
* Known hypersensitivity to any of the anesthetic agents to be used
* Pregnant women
* Lactating women
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT01536002
Study Brief:
Protocol Section:
NCT01536002